metoclopramide has been researched along with Atrophy in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carretero, J | 1 |
| Sánchez, F | 1 |
| Montero, M | 1 |
| González, R | 1 |
| Blanco, E | 1 |
| Riesco, JM | 1 |
| Vázquez, R | 1 |
1 other study available for metoclopramide and Atrophy
| Article | Year |
|---|---|
Morphometric study of the LH-immunoreactive gonadotrophic cells of rats following treatment with methoclopramide.
Topics: Animals; Antibodies; Atrophy; Female; Luteinizing Hormone; Male; Metoclopramide; Pituitary Gland; Ra | 1991 |